Clinical and Radiographic Evaluation of Pulpotomy Using Neoputty MTA Versus Pulpectomy Using Metapex in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis in Children Aged 4 to 9 Years.

itle: Evaluation of Pulpotomy using Neoputty MTA vs. Pulpectomy using Metapex in Children (4-9 years). Objective: Compare clinical and radiographic success of pulpotomy vs. pulpectomy for vital primary molars with irreversible pulpitis. Design: Randomized controlled trial with 2-arm parallel groups. Participants: Healthy children aged 4-9 with specific inclusion/exclusion criteria. Outcomes: Primary (pain relief, absence of complications) and secondary (radiographic success).

NCT Number	NCT06929247
Lead Sponsor	Mohamed Nashaat Mohamed
Conditions	Pulpitis - Irreversible
Enrollment	70 participants
Start Date	2025-04
Primary Completion	2025-04 (estimated)
Study Completion	2026-04 (estimated)
Updated on ClinicalTrials.gov	2025-04-16